Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain

被引:134
作者
Klein, RL [1 ]
Hamby, ME
Gong, Y
Hirko, AC
Wang, S
Hughes, JA
King, MA
Meyer, EM
机构
[1] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Vet Adm Gainesville Med Ctr, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[5] Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA 02129 USA
关键词
adeno-associated virus; dose response; gene therapy; gene transfer; green fluorescent protein; IRES; primary neuronal cultures; promoter; WPRE;
D O I
10.1006/exnr.2002.7942
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies demonstrated that the rat neuron-specific enolase (NSE) promoter is effective for transgene expression in the brain in a variety of adeno-associated virus-2 vectors. This study evaluated the dose response and longer time course of this promoter and compared it to two cytomegalovirus/chicken beta-actin hybrid (CBA) promoter-based systems. NSE promoter-driven green fluorescent protein (GFP)-expressing neurons were found at doses as low as 107 particles, with expression increasing in a dose-dependent manner over a 3.3-log range. Bicistronic expression of GFP via an internal ribosome entry site coupled to the NSE promoter was also dose dependent, although the potency was decreased by 3.4-fold. The number of GFP-expressing neurons was stable for at least 25 months. The CBA promoter increased the numbers of GFP-expressing cells versus the NSE promoter, although the expression pattern remained neuronal and persisted for at least 18 months. The CBA promoter permitted detection of cells distal to the injection site that had retrogradely transported the vector from their terminal areas. Incorporating the woodchuck hepatitis virus post-transcriptional regulatory element (WPRE) into a CBA promoter vector induced greater expression levels in the hippocampus, as measured by stereological estimates of cell numbers and by Western blots, which demonstrated an 11-fold increase. Incorporation of the WPRE also improved transgene expression in primary neuronal cultures. The increased efficiency obtained with vector elements such as the CBA promoter and the WPRE may enhance the ability to genetically modify larger portions of the brain while requiring smaller doses and volumes. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:66 / 74
页数:9
相关论文
共 28 条
[1]   Convection-enhanced delivery of AAV vector in parkinsonian monkeys;: In vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach [J].
Bankiewicz, KS ;
Eberling, JL ;
Kohutnicka, M ;
Jagust, W ;
Pivirotto, P ;
Bringas, J ;
Cunningham, J ;
Budinger, TF ;
Harvey-White, J .
EXPERIMENTAL NEUROLOGY, 2000, 164 (01) :2-14
[2]   Selective and rapid uptake of adeno-associated virus type 2 in brain [J].
Bartlett, JS ;
Samulski, RJ ;
McCown, TJ .
HUMAN GENE THERAPY, 1998, 9 (08) :1181-1186
[3]   Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle [J].
Chirmule, N ;
Xiao, WD ;
Truneh, A ;
Schnell, MA ;
Hughes, JV ;
Zoltick, P ;
Wilson, JM .
JOURNAL OF VIROLOGY, 2000, 74 (05) :2420-2425
[4]   CHARACTERIZATION OF GLUCOCORTICOID TYPE-II RECEPTORS IN NEURONAL AND GLIAL CULTURES FROM RAT-BRAIN [J].
CHOU, YC ;
LUTTGE, WG ;
SUMNERS, C .
JOURNAL OF NEUROENDOCRINOLOGY, 1990, 2 (01) :29-38
[5]   Distribution of AAV-TK following intracranial convection-enhanced delivery into rats [J].
Cunningham, J ;
Oiwa, Y ;
Nagy, D ;
Podsakoff, G ;
Colosi, P ;
Bankiewicz, KS .
CELL TRANSPLANTATION, 2000, 9 (05) :585-594
[6]   Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged β-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice [J].
Daly, TM ;
Okuyama, T ;
Vogler, C ;
Haskins, ME ;
Muzyczka, N ;
Sands, MS .
HUMAN GENE THERAPY, 1999, 10 (01) :85-94
[7]   Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system [J].
Davidson, BL ;
Stein, CS ;
Heth, JA ;
Martins, I ;
Kotin, RM ;
Derksen, TA ;
Zabner, J ;
Ghodsi, A ;
Chiorini, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3428-3432
[8]   DICISTRONIC TRANSCRIPTION UNITS FOR GENE-EXPRESSION IN MAMMALIAN-CELLS [J].
DIRKS, W ;
WIRTH, M ;
HAUSER, H .
GENE, 1993, 128 (02) :247-249
[9]   Novel tools for production and purification of recombinant adenoassociated virus vectors [J].
Grimm, D ;
Kern, A ;
Rittner, K ;
Kleinschmidt, JA .
HUMAN GENE THERAPY, 1998, 9 (18) :2745-2760
[10]   LONG-TERM GENE-EXPRESSION AND PHENOTYPIC CORRECTION USING ADENOASSOCIATED VIRUS VECTORS IN THE MAMMALIAN BRAIN [J].
KAPLITT, MG ;
LEONE, P ;
SAMULSKI, RJ ;
XIAO, X ;
PFAFF, DW ;
OMALLEY, KL ;
DURING, MJ .
NATURE GENETICS, 1994, 8 (02) :148-154